The pivotal phase 3 efficacy study randomized 322 patients after bunionectomy into one of four treatment groups: placebo, 0.5 mg t.i.d.
, 0.25 mg t.i.d.
, or 0.125 mg t.i.d.
10/21/2011 (after over 10 years of continuous L-methionine administration at 250 mg t.i.d.
) ALT 71 U/L (Normal range: 4-45 U/L) AST 78 U/L (Normal range: 7-36 U/L)
iron, that figure rises to 90%, and t.i.d.
dosing bumps up another 5%.
Treatments were administered 1-2 capsules t.i.d.
, each capsule containing between 182 and 200 mg of PO, treatment duration was usually 2-4 weeks.
regimen of U-500 insulin 300-750 U/day t.i.d.
regimen of U-500 insulin 750-2,000 U/day t.i.d.
Study Medication and Dosage: 600 mg N-acetylcysteine (NAC) t.i.d.
(1800 mg/day) plus conventional therapy (prednisone and azathioprine) or placebo plus conventional therapy given for one year.
Drug Dosage Cost/Day* amoxicillin 1.5-4 g/day in $0.38 (500 mg t.i.d.
) divided doses, usually 500 mg t.i.d.
Twenty-one subjects with ischemic heart disease and heart failure were monitored for the effects of Q-Absorb 300 mg daily 100 mg t.i.d.
, exercise therapy and Q-Absorb plus exercise therapy versus placebo.
* Intervention: Eligible subjects were randomly assigned to one of five orally administered treatments: 500 mg glucosamine hydrochloride t.i.d.
, 400 mg sodium chondroitin sulfate t.i.d.
, 500 mg glucosamine plus 400 mg sodium chondroitin sulfate t.i.d.
Start with 60 mg/day (20 mg t.i.d.
) prednisone for 2 weeks tapering to 25 mg per day (10 / 10 / 5 mg) over 6 weeks.
phentermine $1.02 (37.5 mg/day) 18.5-37.5 [Adipex-P] [$1.67] mg/day [Atti-Plex P] [$0.65] [Pro-Fast SR] [$0.89] benzphetamine no generic available 25-50 mg/day [Didrex] [$1.07 (50 mg/day)] phendimetrazine $0.36 (35 mg b.i.d.) 17.5-70 mg [Bontril] [$0.80] b.i.d or t.i.d.
[Obezine] [$0.10] [Phendiet] [$0.08] diethylpropion $0.72 25 mg t.i.d.
In a double-blind, randomized trial, 66 patients who received 200 mg of pregabalin t.i.d.
reduced their baseline Hamilton Anxiety Rating Scale (HAM-A) score from 25.4 to 12.2, which was a significantly larger decrease than 67 patients who received placebo (from 24.8 to 15.5) (J.